Home Watchlist Market News High Impact News Market Movers Screener Portfolio Calculators Heatmap Compare Calendars Crypto Forex Macro Maps

Research Tools

Financial Analysis Analyst Estimates Insider Trading Market Guide Trading Ideas Charts

Financial Analysis

Highlights Income Statement Balance Sheet Cash Flow Multiples Profitability

Loading stock research

Loading market dashboard

My Watchlist

Create an account to keep a persistent watchlist.

Home High Impact News Market Movers

Loading stock research

Cannabis Strategic Ventures

NUGS

HealthcareOTCUS

$0.001

-$0.0003 (-23.08%)

Overview Financials Analysis Valuation Thesis Ownership Compare AI Report News

NUGS

1Y-0.0003 (-23.08%)

Candles, volume, SMA 20, and SMA 50

O 0.001H 0.001L 0.001C 0.001Date Jun 5

NUGS

SMA 20 SMA 50 Vol 30.58K

Open in Chartsfor further analysis

Business Description

Open for the full company profile when you need deeper context.

ShowHide

Cannabis Strategic Ventures engages in the cultivation of marijuana products in the United States. It incubates, develops, and partners within the cannabis and ancillary sectors. The company is based in Los Angeles, California.

Key Metrics

Quick size, liquidity, and volatility measures for the stock.

Market Cap?$187,588

Volume?30.58K

Avg Volume?41.98K

52w Range$0.0001 - $0.005

Beta?-31.42

Price Performance

-16.7%

$0.0012 to $0.001

YTD

+66.7%

$0.0006 to $0.001

+900.0%

$0.0001 to $0.001

-84.6%

$0.0065 to $0.001

-98.6%

$0.07 to $0.001

10Y

-98.1%

$0.053 to $0.001

Company Details

CEO, industry, employees, IPO date, currency, and website.

ShowHide

CEOSimon Yu

IndustryDrug Manufacturers - Specialty & Generic

Employees30

IPO Date2009-07-24

CurrencyUSD

Websitewww.cannabisstrategic.com

Related stocks

Check out other names from the same Drug Manufacturers - Specialty & Generic industry as NUGS.

AOLS-

Aeolus Pharmaceuticals, Inc.

0.00USD

0.00%

CBGI-

The CannaBusiness Group, Inc.

Healthcare Solutions Management Group, Inc.

MPX International Corporation

Petlife Pharmaceuticals, Inc.